Operating Unit Head Cardiovascular, Renal and Metabolic Diseases (CVRM) (m/w/d)
Roche
About this role
The Operating Unit Head CVRM at Roche is a strategic senior leadership role focused on shaping the future growth of cardiovascular, renal and metabolic therapies in Germany. The position drives Roche's market positioning and organizational development in this therapeutic area to improve patient outcomes and establish long-term impact.
Skills
About Roche
roche.comAs a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Recent company news
ReutersRoche chairman still expects diagnostics hit from US tariffs
4 days ago
Oncology PipelineRoche flunks its first-line degrader test | ApexOnco - Clinical Trials news and analysis
3 days ago
BioWorld MedTechRoche to invest ₩710B in South Korea over five years
1 day ago
Bloomberg.comRoche Breast-Cancer Drug Combination Misses Target in Study
3 days ago
Fierce BiotechLilly pledges $500M to South Korea biopharma industry, following Roche’s lead
1 day ago
About Roche
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Roche.
Salary
$206k – $273k
per year
More jobs at Roche
Similar Jobs
Product Manager Cardiovascular, Renal, Metabolic (CVRM)
AstraZeneca
TA Head Cardiovascular, Renal & Metabolic
Diversity Employment
Clinical Science Director, Early Clinical Development, CVRM
AstraZeneca
US Head of Early Assets, CVRM Medical
AstraZeneca
Key Account Manager CVRM - Timisoara
AstraZeneca
Gerente Distrital CVRM - Fortaleza, Aracaju ou Teresina (Temporário)
AstraZeneca